277 related articles for article (PubMed ID: 17591570)
1. Pediatric hodgkin lymphoma: maximizing efficacy and minimizing toxicity.
Hodgson DC; Hudson MM; Constine LS
Semin Radiat Oncol; 2007 Jul; 17(3):230-42. PubMed ID: 17591570
[TBL] [Abstract][Full Text] [Related]
2. Twenty-year disease and treatment-associated mortality rates of patients with Hodgkin lymphoma of clinical stages IIIB and IV prospectively treated with 3-month anthracycline-based chemotherapy followed by extended high-dose radiation.
Sénécal D; Jais JP; Desablens B; Berthou C; Casassus P; Moles MP; Delwail V; Gastinne T; Colonna P; Andrieu JM
Cancer; 2008 Feb; 112(4):846-55. PubMed ID: 18072259
[TBL] [Abstract][Full Text] [Related]
3. Involved-nodal radiation therapy as a component of combination therapy for limited-stage Hodgkin's lymphoma: a question of field size.
Campbell BA; Voss N; Pickles T; Morris J; Gascoyne RD; Savage KJ; Connors JM
J Clin Oncol; 2008 Nov; 26(32):5170-4. PubMed ID: 18838714
[TBL] [Abstract][Full Text] [Related]
4. The impact of involved field radiation therapy for patients receiving high-dose chemotherapy followed by hematopoietic progenitor cell transplant for the treatment of relapsed or refractory Hodgkin disease.
Wendland MM; Asch JD; Pulsipher MA; Thomson JW; Shrieve DC; Gaffney DK
Am J Clin Oncol; 2006 Apr; 29(2):189-95. PubMed ID: 16601441
[TBL] [Abstract][Full Text] [Related]
5. Final results of a prospective clinical trial with VAMP and low-dose involved-field radiation for children with low-risk Hodgkin's disease.
Donaldson SS; Link MP; Weinstein HJ; Rai SN; Brain S; Billett AL; Hurwitz CA; Krasin M; Kun LE; Marcus KC; Tarbell NJ; Young JA; Hudson MM
J Clin Oncol; 2007 Jan; 25(3):332-7. PubMed ID: 17235049
[TBL] [Abstract][Full Text] [Related]
6. Will BEACOPP be the standard for high risk Hodgkin lymphoma patients in advanced stages?
Diehl V; Fuchs M;
Transfus Apher Sci; 2007 Aug; 37(1):37-41. PubMed ID: 17714996
[TBL] [Abstract][Full Text] [Related]
7. Combined modality treatment of Hodgkin's lymphoma.
Klimm B; Engert A
Cancer J; 2009; 15(2):143-9. PubMed ID: 19390310
[TBL] [Abstract][Full Text] [Related]
8. Controversies in radiotherapy for pediatric Hodgkin's lymphoma.
Wiegner EA; Donaldson SS
Expert Rev Anticancer Ther; 2011 Sep; 11(9):1357-66. PubMed ID: 22029056
[TBL] [Abstract][Full Text] [Related]
9. [Treatment results of stage IA Hodgkin lymphoma: a report of 97 cases].
Tan WY; Hu DS; Zeng FY; Song QB; Hu S; Wei L; Zhou LQ
Ai Zheng; 2007 Dec; 26(12):1360-4. PubMed ID: 18076802
[TBL] [Abstract][Full Text] [Related]
10. First-line treatment of Hodgkin's lymphoma.
Klimm B; Engert A; Diehl V
Curr Hematol Rep; 2005 Jan; 4(1):15-22. PubMed ID: 15610655
[TBL] [Abstract][Full Text] [Related]
11. Involved-field radiotherapy before high-dose therapy and autologous stem-cell rescue in diffuse large-cell lymphoma: long-term disease control and toxicity.
Hoppe BS; Moskowitz CH; Filippa DA; Moskowitz CS; Kewalramani T; Zelenetz AD; Yahalom J
J Clin Oncol; 2008 Apr; 26(11):1858-64. PubMed ID: 18332466
[TBL] [Abstract][Full Text] [Related]
12. Early versus late intensification for patients with high-risk Hodgkin lymphoma-3 cycles of intensive chemotherapy plus low-dose lymph node radiation therapy versus 4 cycles of combined doxorubicin, bleomycin, vinblastine, and dacarbazine plus myeloablative chemotherapy with autologous stem cell transplantation: five-year results of a randomized trial on behalf of the GOELAMS Group.
Arakelyan N; Berthou C; Desablens B; de Guibert S; Delwail V; Moles MP; Quittet P; Jais JP; Colonna P; Andrieu JM;
Cancer; 2008 Dec; 113(12):3323-30. PubMed ID: 18988286
[TBL] [Abstract][Full Text] [Related]
13. Two cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine plus extended-field radiotherapy is superior to radiotherapy alone in early favorable Hodgkin's lymphoma: final results of the GHSG HD7 trial.
Engert A; Franklin J; Eich HT; Brillant C; Sehlen S; Cartoni C; Herrmann R; Pfreundschuh M; Sieber M; Tesch H; Franke A; Koch P; de Wit M; Paulus U; Hasenclever D; Loeffler M; Müller RP; Müller-Hermelink HK; Dühmke E; Diehl V
J Clin Oncol; 2007 Aug; 25(23):3495-502. PubMed ID: 17606976
[TBL] [Abstract][Full Text] [Related]
14. [Preliminary results of thyroid function assessment in children and adolescents with Hodgkin's disease (HD) treated according to PGP-HD-97 protocol].
Moryl-Bujakowska A; Balwierz W; Sztefko K
Przegl Lek; 2004; 61 Suppl 2():81-4. PubMed ID: 15686053
[TBL] [Abstract][Full Text] [Related]
15. Treatment of pediatric Hodgkin's lymphoma.
Hudson MM; Donaldson SS
Semin Hematol; 1999 Jul; 36(3):313-23. PubMed ID: 10462331
[TBL] [Abstract][Full Text] [Related]
16. New strategies for the treatment of advanced-stage Hodgkin's lymphoma.
Diehl V; Engert A; Re D
Hematol Oncol Clin North Am; 2007 Oct; 21(5):897-914. PubMed ID: 17908627
[TBL] [Abstract][Full Text] [Related]
17. Current strategies in the treatment of childhood Hodgkins disease.
Arya LS; Dinand V
Indian Pediatr; 2005 Nov; 42(11):1115-28. PubMed ID: 16340052
[TBL] [Abstract][Full Text] [Related]
18. Hodgkin's lymphoma in the young child.
Belgaumi AF
Transfus Apher Sci; 2010 Apr; 42(2):163-7. PubMed ID: 20100668
[TBL] [Abstract][Full Text] [Related]
19. Radiotherapy in early stage classical Hodgkin lymphoma: past, present and future.
Zhang W
Chin Clin Oncol; 2015 Mar; 4(1):6. PubMed ID: 25841713
[TBL] [Abstract][Full Text] [Related]
20. Involved field radiotherapy for limited stage Hodgkin lymphoma: balancing treatment efficacy against long-term toxicities.
Goda JS; Tsang RW
Hematol Oncol; 2009 Sep; 27(3):115-22. PubMed ID: 19274613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
